These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22032910)

  • 41. Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers.
    Kenkhuis MJ; de Bock GH; Elferink PO; Arts HJ; Oosterwijk JC; Jansen L; Mourits MJ
    Maturitas; 2010 Jul; 66(3):310-4. PubMed ID: 20409655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk reduction works for BRCA mutation carriers--with heavy costs.
    Vanchieri C
    J Natl Cancer Inst; 2005 Jul; 97(14):1032-3. PubMed ID: 16030299
    [No Abstract]   [Full Text] [Related]  

  • 43. The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations.
    Grann VR; Jacobson JS; Sundararajan V; Albert SM; Troxel AB; Neugut AI
    Cancer J Sci Am; 1999; 5(5):283-92. PubMed ID: 10526669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.
    Beattie MS; Crawford B; Lin F; Vittinghoff E; Ziegler J
    Genet Test Mol Biomarkers; 2009 Feb; 13(1):51-6. PubMed ID: 19309274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers.
    Hagen AI; Mæhle L; Vedå N; Vetti HH; Stormorken A; Ludvigsen T; Guntvedt B; Isern AE; Schlichting E; Kleppe G; Bofin A; Gullestad HP; Møller P
    Breast; 2014 Feb; 23(1):38-43. PubMed ID: 24210736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.
    Dowdy SC; Stefanek M; Hartmann LC
    Am J Obstet Gynecol; 2004 Oct; 191(4):1113-23. PubMed ID: 15507929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk-reducing mastectomy for the prevention of primary breast cancer.
    Carbine NE; Lostumbo L; Wallace J; Ko H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD002748. PubMed ID: 29620792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Choices--and uncertainties--for women with BRCA mutations.
    Couzin J
    Science; 2003 Oct; 302(5645):592. PubMed ID: 14576419
    [No Abstract]   [Full Text] [Related]  

  • 49. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.
    Metcalfe KA; Esplen MJ; Goel V; Narod SA
    Psychooncology; 2004 Jan; 13(1):14-25. PubMed ID: 14745742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
    Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Seynaeve C; van Geel AN; Tilanus MM; Bartels CC; Verhoog LC; Brekelmans CT; Burger CW; Niermeijer MF
    Breast Cancer Res Treat; 2002 May; 73(2):97-112. PubMed ID: 12088120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breast reconstruction in patients with personal and family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year experience.
    Unukovych D; Sandelin K; Wickman M; Arver B; Johansson H; Brandberg Y; Liljegren A
    Acta Oncol; 2012 Sep; 51(7):934-41. PubMed ID: 22409595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.
    Howard AF; Bottorff JL; Balneaves LG; Kim-Sing C
    BMC Womens Health; 2010 Aug; 10():24. PubMed ID: 20687957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The option of delayed reconstructive surgery following mastectomy for invasive breast cancer: why do so few patients embrace this offer?
    Lardi AM; Myrick ME; Haug M; Schaefer DJ; Bitzer J; Simmen U; Güth U
    Eur J Surg Oncol; 2013 Jan; 39(1):36-43. PubMed ID: 22967961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effect of prophylactic mastectomy with recontruction on quality of life in BRCA positive women].
    Spurná Z; Dražan L; Foretová L; Dvorská L
    Klin Onkol; 2012; 25 Suppl():S74-7. PubMed ID: 22920211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers.
    Nagura N; Hayashi N; Takei J; Yoshida A; Ochi T; Iwahira Y; Yamauchi H
    Breast Cancer; 2020 Jan; 27(1):70-76. PubMed ID: 31292927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re: Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation carriers.
    Foulkes WD
    J Natl Cancer Inst; 2003 Sep; 95(17):1344; author reply 1344. PubMed ID: 12953090
    [No Abstract]   [Full Text] [Related]  

  • 58. Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study.
    Metcalfe KA; Semple JL; Narod SA
    Plast Reconstr Surg; 2004 Aug; 114(2):360-6. PubMed ID: 15277800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast sensibility after bilateral risk-reducing mastectomy and immediate breast reconstruction: a prospective study.
    Gahm J; Hansson P; Brandberg Y; Wickman M
    J Plast Reconstr Aesthet Surg; 2013 Nov; 66(11):1521-7. PubMed ID: 23953096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations.
    Julian-Reynier C; Mancini J; Mouret-Fourme E; Gauthier-Villars M; Bonadona V; Berthet P; Fricker JP; Caron O; Luporsi E; Noguès C
    Eur J Hum Genet; 2011 May; 19(5):500-6. PubMed ID: 21267012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.